brilinta - ticagrelor tablet
(Ticagrelor)Astrazeneca Pharmaceuticals Lp
Usage: Brilinta reduces the risk of cardiovascular death, heart attack, and stroke in patients with acute coronary syndrome or prior heart attack. It also lowers the risk of first heart attack or stroke in high-risk coronary artery disease patients, and reduces stroke risk after mild ischemic stroke or high-risk TIA.